ViiV Healthcare Limited

The FDA approves GSK's Hybsago as a fixed-duration functional cure option for chronic hepatitis B.

And CSL names Debra Waterhouse departing Viiv Healthcare as its next CEO and managing director.

The Institute for Clinical and Economic Review and West Health release a new launch price and access report, finding that the median net launch price for new drugs rose thirty-five percent from one hundred ninety thousand dollars in twenty twenty-two to two hundred fifty-seven thousand dollars in twenty twenty-five, with about one in four drugs launched in twenty twenty-five priced above five hundred thousand dollars annually.

The report also finds only one-third of outpatient prescriptions are filled within thirty days of an attempted fill, with Medicare recipients facing higher coverage rejection rates than other payers.

In pooled data from the Phase three B well one and B well two trials, nineteen percent of treated participants achieved functional cure after a six-month course, versus none on placebo, rising to twenty-six percent among those with lower baseline surface antigen levels.

The approval extends the drug to a US patient population GSK estimates at about one point seven million people.

Finally, CSL names Debra Waterhouse as Chief Executive Officer and Managing Director, drawing her from Viiv Healthcare, where she has served as CEO since twenty seventeen.

Waterhouse's move takes effect February first, twenty twenty-seven, with Gordon Naylor continuing as CSL's interim CEO until then, while Lynne Baxter is set to succeed her at Viiv effective November first, twenty twenty-six.

They had a government affairs.

We were actually in the Dáil there today, and, uh, we were having this, like, um, it was like a cross-party, uh, discussion, and I wasn't supposed to say anything about access to medicines, but they were all there, uh, Merck, ViiV, and thinking, I was like, and I, I was the moderator, so I had the power.

And so I gave my little speech that was pre-prepared for me, and then I was like, I turned around to them, I was like, "Where the hell's our PrEP?" [laughs] And they nearly died.

And then Padraig, um, oh, what's his name? Padraig Reidy.

And the whole point of it, we're...

The event is helped out by our partners from Gilead and ViiV.

It's really to educate people on the importance of PrEP and hopefully get people signed up for PrEP as well.

Because there is an education gap.